Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Jones Kenneth T was granted 9,000 shares and sold $3,321 worth of shares (2,505 units at $1.33), increasing direct ownership by 8% to 85,520 units

ByQuantisnow·Wall Street's wire, on your screen.
ZYNE· Zynerba Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Jones Kenneth T was granted 9,000 shares and sold $3,321 worth of shares (2,505 units at $1.33), increasing direct ownership by 8% to 85,520 units | Quantisnow